Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention: The GRAVITAS Randomized Trial

Study Questions:

Do patients with high on-treatment platelet reactivity after percutaneous coronary intervention (PCI) derive clinical benefit from high-dose clopidogrel?